IDEA Collider: Innovation & Asymmetric Learning in Pharma

AI-Driven Pharma Market Research: Synthetic Users - with Kwame Ferreira & Rebecca Gould.
Welcome back to the IDEA Collider podcast. In this episode, host Rick Ritacco sits down with Kwame Ferreira, Founder of Synthetic Users, and Rebecca Gould, President, Strategic Consulting & Analytics Business Unit at SAI. Together, they explore how artificial intelligence and synthetic behavioral modeling are transforming pharmaceutical market research and insight generation. For decades, market research operated under a strict constraint: you could choose two between speed, price, and quality, but never all three. Rebecca and Kwame discuss how synthetic user technology breaks this triangle, allowing biopharma teams to generate high-quality qualitative insights rapidly and cost-effectively. Kwame breaks down the architecture behind synthetic users - defining them as an abstraction of brain architecture that replicates human emotional responses, cognitive biases, and system 1 behaviors rather than striving for super intelligence. Rebecca shares real-world case studies in rare diseases, competitive simulation workshops, and creative concept testing where synthetic personas achieved over 90% parity with live human respondents. Tune in to discover how synthetic research is empowering healthcare leaders to make faster, higher-confidence decisions across the thousands of choices required to bring a medicine to market. Keep up with the Guests Rebecca Gould's LinkedIn: https://www.linkedin.com/in/rebecca-gould-b30b73/ Kwame Ferreira's LinkedIn: https://www.linkedin.com/in/kwame-ferreira-1b06a31/ Keep up with Rick Ritacco: LinkedIn: https://www.linkedin.com/in/rritacco/ Follow IDEA Pharma On; Website: https://www.ideapharma.com/ Listen to more fantastic podcast episodes: https://ideacollider.simplecast.com/
Audio and video play straight from the show's own hosting. PodSubs stores and serves no media.
